Launch

Bringing your new drug to the market

Once you’ve received FDA approval and you’re ready to launch your drug, there’s a lot of work to be done still, including keeping tabs on the competition and market landscape, making sure your drug is visible in EHR platforms, and continuing to track and integrate your data. Of course, there’s also a lot of legwork involved in managing your inventory, implementing patient support strategies, and being quick on your feet to identify and resolve issues quickly as they arise.

The good news is we’re here for you. Not only do we have the insight and expertise needed to make sound, insightful decisions, but our growing team of industry professionals are able to handle much of the implementation for you, meaning you can focus on the big picture while letting us handle the details.

Services We Recommend at
Launch Phase

Commercialization


Managing the logistics and flow of information about your new retail product is a key to being as efficient as possible with your commercialization efforts.
Bringing specialty drugs to market, while increasingly common, requires properly managing your channel and the flow of data and analytics.
Ensuring that patients, healthcare providers and caregivers all have the information they need to access and properly use your treatment is important for all new drug launches.
Many see compendia databases as just a pricebook, but they’re so much more. In fact, an incorrect classification can mean a failed launch.
In many ways, timely state licensing is just as important for your launch as the FDA approval process.
Expecting EHR visibility without a proactive and reactive approach equates to lost sales, especially with the prevalence of e-prescribing in today’s market.
From choosing the right 3PL partner to tracking and analyzing performance, optimizing your trade strategy is a significant part of commercial success.

Market Access


To maximize your revenue, it’s vital that you develop proper strategy that takes payers, physicians and patients into consideration.
Gaining a thorough understanding of the market, as well as the future environment, is critical for sound decision making.
It’s imperative manufacturers have a thorough understanding of out of pocket (OOP) costs and the reimbursement support options available to them.
To understand the pricing and market access potential for new treatments, clients need to hear from KOLs and payers. At Two Labs, we conduct blinded and unblinded panels, depending on your needs.
In today’s competitive landscape, a one-size-fits-all approach to your market access strategy is not enough.
An engagement strategy that effectively communicates with payers to achieve favorable access is paramount to the successful launch of a product.

Market Intelligence


Increase your awareness of your drug’s disease landscape and competitor activities to determine how to differentiate your drug in the market to be successful.
Save time and money without losing out on important developments in the pharma world with our full medical congress coverage services.
Understand what physicians and patients want to see from your new product with our in-depth primary source interviewing services.
Gain the most from your benchmarking study with our key insights, complete with an action list and detailed recommendations.
Our extensive experience monitoring and assessing all therapeutic categories allows us to provide insights to support licensing and acquisition decisions.
Our Competitive Simulations are your key to deeper competitor insight and a smarter business development strategy.